ストックスクリーナーアプリを入手
81.66
3.79%
2.98
前日終値:
$78.68
開ける：
$79.54
24時間の取引高:
1.29M
Relative Volume:
0.98
時価総額：
$10.96B
収益：
$3.10B
当期純損益:
$586.71M
株価収益率:
19.02
EPS:
4.2937
ネットキャッシュフロー:
$605.57M
1週間 パフォーマンス:
+6.45%
1か月 パフォーマンス:
+10.41%
6か月 パフォーマンス:
-13.48%
1年 パフォーマンス:
+30.03%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$75.43
$81.83
52週間の値動き範囲:
$59.51
$101.40
Globus Medical Inc Stock (GMED) Company Profile
名前
Globus Medical Inc
セクター
電話
610-930-1800
住所
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
81.66 | 10.96B | 3.10B | 586.71M | 605.57M | 4.2937 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-07-28 | 開始されました | UBS | Neutral |
| 2026-07-09 | 開始されました | BMO Capital Markets | Outperform |
| 2026-01-30 | アップグレード | Needham | Hold → Buy |
| 2026-01-27 | 開始されました | TD Cowen | Buy |
| 2025-11-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-11-07 | アップグレード | Truist | Hold → Buy |
| 2025-10-28 | 再開されました | Stifel | Hold |
| 2025-05-27 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-01-10 | アップグレード | BofA Securities | Underperform → Neutral |
| 2024-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-10-20 | 開始されました | ROTH MKM | Buy |
| 2023-09-19 | アップグレード | Stifel | Hold → Buy |
| 2023-03-30 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-02-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-02-10 | ダウングレード | Loop Capital | Buy → Hold |
| 2023-02-10 | ダウングレード | Needham | Buy → Hold |
| 2023-02-10 | ダウングレード | Truist | Buy → Hold |
| 2023-02-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-04-13 | 再開されました | Truist | Buy |
| 2022-03-28 | 開始されました | Wells Fargo | Overweight |
| 2022-01-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | アップグレード | BofA Securities | Underperform → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-10-29 | 開始されました | Loop Capital | Buy |
| 2021-02-18 | 再開されました | Needham | Buy |
| 2020-12-08 | 開始されました | Citigroup | Buy |
| 2020-10-20 | 開始されました | Stifel | Hold |
| 2020-08-06 | 繰り返されました | Needham | Buy |
| 2020-08-06 | アップグレード | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | 開始されました | Northland Capital | Market Perform |
| 2020-07-06 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | 繰り返されました | Needham | Buy |
| 2020-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2019-12-12 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | 繰り返されました | Needham | Buy |
| 2019-05-24 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | 繰り返されました | Needham | Buy |
| 2019-02-28 | アップグレード | UBS | Neutral → Buy |
| 2019-01-02 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-27 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-05-03 | 繰り返されました | Needham | Buy |
| 2018-04-04 | アップグレード | Needham | Hold → Buy |
すべてを表示
Globus Medical Inc (GMED) 最新ニュース
DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? - Zacks Investment Research
BDX Stock Gains 25.5% in Six Months: What's Behind the Rally? - Zacks Investment Research
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market - Zacks Investment Research
GEHC Expands Theranostics Imaging With 5 Global Collaborations - Zacks Investment Research
Revvity Launches Signals LabGistics to Coordinate Scientific Workflows - Zacks Investment Research
Globus Medical (NYSE:GMED): A Balanced Affordable Growth Case - ChartMill
Kuehn Law Encourages Investors of Globus Medical, Inc. to Contact Law Firm - Morningstar
A Look at Globus Medical Inc (GMED) After 4.4% Gain -- GF Value $97.21 vs Price $78.96 - GuruFocus
Globus Medical Sets November 5 Earnings Report and Call - MyChesCo
Globus Medical, Inc. (GMED) Stock Forecasts - Yahoo! Finance Canada
GMED or AXGN: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Reasons to Add STE Stock to Your Portfolio Right Now - Zacks Investment Research
Haemonetics Gains 149.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Is it Apt to Retain Medtronic Stock in Your Portfolio Now? - Zacks Investment Research
Is Spine Tech Unveiling Altering The Investment Case For Globus Medical Stock? - Yahoo Finance
RBC cuts target to USD 85.00 for Globus Medical stock - ad-hoc-news.de
BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients - Zacks Investment Research
Doximity Deepens U.S. News Alliance to Improve Patient Access to Care - Zacks Investment Research
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research
Is Globus Medical (GMED) Cheap On Its Spine Platform Reveal? - Yahoo Finance
What Does Globus Medical (GMED) Mean For Spine Care After Its NASS 2026 Reveal? - Yahoo Finance
Globus Medical (GMED) Stock Looks Discounted Against Its Earnings Outlook - Yahoo Finance
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026 - Orthopedics This Week
Glaukos Stock Gains 36.8% in 6 Months: What's Behind the Rally? - Zacks Investment Research
Globus Medical, Inc. (GMED.MX) stock price, news, quote and history - Yahoo Finance UK
BTSG Stock Climbs 67.3% YTD: What's Driving the Rally in 2026? - Zacks Investment Research
Reasons to Add QuidelOrtho Stock to Your Portfolio for Now - Zacks Investment Research
Hims & Hers Expands Australian Women's Health Platform With Hers - Zacks Investment Research
A new platform is designed to let surgeons tailor spinal implants to each patient. Globus Medical will preview it at NASS. - Stock Titan
Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026 - GlobeNewswire
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research
ISRG Is Expanding Beyond Surgery: Here's Why the GI Opportunity Matters - Zacks Investment Research
Here's Why You Should Add Avantor Stock to Your Portfolio for Now - Zacks Investment Research
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - Zacks Investment Research
Globus Medical to Announce Third Quarter 2026 Financial Results on November 5 and Hold Conference Call - Quiver Quantitative
Globus Medical Schedules Third Quarter Earnings Release and Conference Call - GlobeNewswire
Globus Medical Schedules Third Quarter Earnings Release and Conference Call - Yahoo Finance
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - Zacks Investment Research
Globus Medical Q2 2026 Earnings Call Transcript - Benzinga
How Globus Medical Inc. Class A (GMED) Affects Rotational Strategy Timing - Stock Traders Daily
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y - Zacks Investment Research
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Is it the Right Time to Hold TNDM Stock in Your Portfolio? - Zacks Investment Research
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now - Zacks Investment Research
Globus Medical, Inc. (GMED) Stock Forecasts - Yahoo Finance
Globus Medical, Inc. (GMED) Stock forecasts - Yahoo Finance Singapore
RBC cuts target for Globus Medical stock to USD 85.00 - AD HOC NEWS
Is it the Right Time to Add Phibro Stock to Your Portfolio? - Zacks Investment Research
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets - Zacks Investment Research
Reasons to Retain Hims & Hers Stock in Your Portfolio for Now - Zacks Investment Research
Globus Medical Inc (GMED) 財務データ
収益
当期純利益
現金流量
EPS
Globus Medical Inc (GMED) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| TOBIN JAMES R | Director |
Sep 15 '26 |
Proposed Sale |
74.53 |
30,000 |
2,236,000 |
0 |
| TOBIN JAMES R | Director |
Sep 15 '26 |
Sale |
74.58 |
30,000 |
2,237,502 |
0 |
| ZARRILLI STEPHEN T | Director |
Aug 18 '26 |
Option Exercise |
53.27 |
25,000 |
1,331,750 |
25,000 |
| ZARRILLI STEPHEN T | Director |
Aug 18 '26 |
Sale |
87.04 |
25,000 |
2,175,965 |
0 |
| ZARRILLI STEPHEN T | Director |
Aug 18 '26 |
Proposed Sale |
87.04 |
25,000 |
2,176,000 |
0 |
| Davidar David D | Director |
Jun 05 '26 |
Proposed Sale |
81.00 |
25,000 |
2,025,000 |
0 |
| Davidar David D | Director |
Jun 05 '26 |
Option Exercise |
26.27 |
25,000 |
656,750 |
535,175 |
| Davidar David D | Director |
Jun 05 '26 |
Sale |
80.76 |
25,000 |
2,019,072 |
510,175 |
| RHOADS ANN D | Director |
Jun 04 '26 |
Option Exercise |
26.27 |
25,000 |
656,750 |
40,384 |
| DeFord John A | Former Director |
Apr 14 '26 |
Proposed Sale |
93.10 |
30,000 |
2,793,128 |
0 |
0.09%
4.38%
大文字化:
|
ボリューム (24 時間):